Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

United States

 

Selling whole genome sequencing to consumers

Javier Echevarria, CEO, Europe and LatAm of Veritas International (VI) has one of the most interesting challenges in marketing - how do you persuade wealthy consumers to spend around $2,000 on predictive whole genome sequencing (WGS)?  He has a broad canvas - his remit is to sell across LatAm, UAE, Europe and Japan.
March 6, 2019

GE Healthcare “files papers for IPO”

American multinational conglomerate General Electric has filed the paperwork to IPO its healthcare arm in mid-2019, according to reports in the US.
December 20, 2018

Interview: Michael Sandhu, Remedium RT

After a long career at radiotherapy supplier Varian where he ended as Vice President, Global Market Development, Michael has set up his own consultancy to advise governments, international agencies and the private sector on the development of radiation therapy services in general and the best business models.  HBI asks him where the opportunities are and what they look like. 
December 12, 2018

KKR ‘nearing deal to buy Acadia’

The American press is reporting that US-based private equity giant KKR is ‘nearing a deal’ to buy addiction treatment specialists Acadia Healthcare. The purchase would bring one of America's largest PE giants into the UK healthcare industry for the first time. How are KKR's international healthcare investments fairing?
November 7, 2018

Spanish hospital group continues expansion in South America

Grupo Hospiten, a Spain-based hospital group with a presence in South America, has opened a new hospital in Mexico. We speak to the company's corporate medical director about its business, its market and its strategy in the region.
October 24, 2018

Quest Diagnostics changes strategy in emerging markets

Last week Healthcare Nova reported that US-based lab company Quest Diagnostics had sold its Indian medical diagnostics arm to Strand Life Sciences. We also reported that Quest has set up an international alliance of lab companies based in Brazil, Saudi Arabia, Korea, Hong Kong and Australia. Are the two moves connected? We speak to Quest's MD of global markets, Mark Machulcz to find out more about the group's change of strategy.
October 24, 2018
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us